Adults with diabetes and CKD, low blood pressure target ( 120 systolic mm Hg) versus standard blood pressure target ( 140 systolic mm Hg) Table S56. Adults with diabetes and CKD, low blood pressure target (<80 diastolic mm Hg) versus standard blood pressure target (80-89 diastolic mm Hg) Table S57. Adults with diabetes and CKD, low blood pressure target (<130/80 mm Hg) plus multifactorial care versus usual care Table S58. Adults with CKD and low proteinuria (PCR 0.22 g/g and PE <0.3 g/d), low MAP target (<92 mm Hg) versus standard MAP target (102 107 mm Hg) Table S59. Adults with CKD and high proteinuria (PCR >0.22 g/g and PE >0.3 g/d), low MAP target (<92 mm Hg) versus standard MAP target (102 107 mm Hg) Table S60. Adults with CKD, ACEi versus placebo or standard of care Table S61. Adults with CKD, ARB versus placebo or standard of care Table S62. Adults with CKD, aldosterone antagonist versus placebo or standard of care Table S63. Adults with CKD, beta-blocker versus placebo or standard of care Table S64. Adults with CKD, beta-blocker versus RASi Table S65. Adults with CKD, calcium channel blockers versus placebo Table S66. Adults with CKD, calcium channel blockers versus RASi Table S67. Adults with CKD, direct renin inhibitor versus placebo Table S68. Adults with CKD, direct renin inhibitor versus RASi Table S69. Adults with CKD, direct renin inhibitor D ACEi or ARB versus placebo or standard of care Table S70. Adults with CKD, diuretics versus RASi Table S71. Older adults with CKD (65 85 years old), high-dose ARB versus calcium channel blocker combined with ARB Table S72. Adults with CKD, type 2 diabetes, and moderately increased albuminuria, calcium channel blockers D RAS blockade versus RAS blockade Table S73. 